Previous 10 | Next 10 |
2023-08-05 16:00:22 ET The US could see the largest number of approvals for medtech devices in around 10 years given the high number of approvals the US FDA granted in the first half of 2023. The agency's Center for Devices and Radiological Health in H1 approved or cleared 45 new device...
NORTHAMPTON, MA / ACCESSWIRE / August 3, 2023 / Boston Scientific Originally published by CAREERS & the disABLED Bird & MacDonald Advocate for Inclusion at Boston Scientific HAVING DEVOTED HER ENTIRE CAREER TO DIVERSITY, EQUITY, AND INCLUSION (DEI) WORK, SHANI BIRD HAS LED DEI EFFOR...
2023-08-02 08:23:00 ET Summary We’ve seen a shift in analyst sentiment over the last two weeks when looking at data in This Week in Earnings and STOXX 600 Earnings Outlook report. For the S&P 500, the week ending July 28th saw a total of 2,444 FY1 EPS revisions over a 7...
ARLINGTON, Va., July 31, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1, 2023. Jeff Bernstein, Managing Director of Goldman Sachs, will resign from the Board eff...
2023-07-30 00:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-07-27 18:04:31 ET Summary GE HealthCare Technologies' revenue growth is expected to benefit from price increases, healthy end-market demand, and increasing digitization in healthcare. The company reported better-than-expected Q2 2023 earnings, with revenue increasing by 9.1% ...
2023-07-27 11:13:12 ET Boston Scientific Corporation (BSX) Q2 2023 Earnings Conference Call July 27, 2023 07:30 AM ET Company Participants Lauren Tengler - VP, IR Mike Mahoney - Chairman & CEO Dan Brennan - EVP & CFO Kenneth Stein - Chief Medical Offi...
2023-07-27 06:39:18 ET Boston Scientific press release ( NYSE: BSX ): Q2 Non-GAAP EPS of $0.53 beats by $0.04 . Revenue of $3.59B (+10.8% Y/Y) beats by $90M . MedSurg: 9.0 percent reported, 9.6 percent operational and 8.8 percent organic Cardiovascular: 12....
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023 PR Newswire MARLBOROUGH, Mass. , July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 per...
2023-07-26 12:30:40 ET Boston Scientific ( NYSE: BSX ) is scheduled to announce Q2 earnings results on Thursday, July 27th, before market open. The consensus EPS Estimate is $0.49 (+11.4% Y/Y) and the consensus Revenue Estimate is $3.5B (+8% Y/Y). Over the last 2 years...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...